These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 6140032

  • 21. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I.
    Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
    [No Abstract] [Full Text] [Related]

  • 22. Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates.
    Lohr JB, Lohr MA, Wasli E, Hilliard B, Larson L, Vardiman E, Wade L, Jeste DV.
    Psychopharmacol Bull; 1987; 23(1):211-4. PubMed ID: 2885888
    [No Abstract] [Full Text] [Related]

  • 23. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract] [Full Text] [Related]

  • 24. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
    Jeste DV, Neckers LM, Wagner RL, Wise CD, Staub RA, Rogol A, Potkin SG, Bridge TP, Wyatt RJ.
    J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
    [Abstract] [Full Text] [Related]

  • 25. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S, Debsikdar V.
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [Abstract] [Full Text] [Related]

  • 26. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE, Kuskowski MA, Caligiuri MP.
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [Abstract] [Full Text] [Related]

  • 27. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
    Keck PE, McElroy SL, Strakowski SM, Soutullo CA.
    J Clin Psychiatry; 2000 Dec; 61 Suppl 4():33-8. PubMed ID: 10739329
    [Abstract] [Full Text] [Related]

  • 28. Tardive dystonia provoked by concomitantly administered risperidone.
    Tachikawa H, Suzuki T, Kawanishi Y, Hori M, Hori T, Shiraishi H.
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):503-5. PubMed ID: 10997870
    [Abstract] [Full Text] [Related]

  • 29. Antipsychotic drugs: current use and future prospects.
    Livingston M.
    Biomed Pharmacother; 1987 Aug; 41(1):34-6. PubMed ID: 2886160
    [Abstract] [Full Text] [Related]

  • 30. Antipsychotic-induced movement disorders - forgotten but not gone.
    Weiden PJ.
    Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315
    [No Abstract] [Full Text] [Related]

  • 31. [Tardive dyskinesia (review of the literature)].
    Lerner VE.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Jun; 88(2):124-32. PubMed ID: 2897750
    [No Abstract] [Full Text] [Related]

  • 32. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
    Kulik FA, Wilbur R.
    Psychopharmacol Bull; 1980 Jul; 16(3):18-9. PubMed ID: 6105690
    [No Abstract] [Full Text] [Related]

  • 33. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 34. Cognitive impairment in tardive dyskinesia.
    Wegner JT, Kane JM, Weinhold P, Woerner M, Kinon B, Lieberman J.
    Psychiatry Res; 1985 Dec; 16(4):331-7. PubMed ID: 2868476
    [Abstract] [Full Text] [Related]

  • 35. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA, Haugland G, Craig TJ.
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [Abstract] [Full Text] [Related]

  • 36. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L, Caligiuri MP, Williams R, Schieldrop P, Manchanda R, Malla A, Harricharan R.
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [Abstract] [Full Text] [Related]

  • 37. Haloperidol update: 1975.
    Ayd FJ.
    Proc R Soc Med; 1976 Feb; 69 suppl 1(Suppl 1):14-22. PubMed ID: 1019142
    [No Abstract] [Full Text] [Related]

  • 38. Early onset of tardive dyskinesia: case report.
    Chouinard G, Jones BD.
    Am J Psychiatry; 1979 Oct; 136(10):1323-4. PubMed ID: 39454
    [No Abstract] [Full Text] [Related]

  • 39. Tardive dyskinesia.
    McAfee HA.
    Am J Nurs; 1978 Mar; 78(3):359-7. PubMed ID: 25020
    [No Abstract] [Full Text] [Related]

  • 40. [Main side effects of the use of neuroleptics].
    Morato GS, Takahashi RN.
    AMB Rev Assoc Med Bras; 1982 Mar; 28(11-12):247-9. PubMed ID: 6133319
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.